1148456

Raphael J. Landovitz, M.D. — FEI 3019716334

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 30, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)